Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Study of XL999 in Patients With Metastatic Renal Cell Carcinoma
This study has been terminated.
( Development of XL999 was stopped due to cardiac toxicities in the subjects )
Study NCT00277316 Information provided by Symphony Evolution, Inc.
First Received on January 12, 2006. Last Updated on February 18, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Renal Cell Carcinoma
Additional conditions recognized in this trial
Carcinoma, Renal Cell
More general conditions related to this trial
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Interventions listed in this trial
Sponsors listed in this trial
Symphony Evolution, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers